Texas high court hears challenge to agency's classification of delta-8 THC and scope of regulator's authority

The Supreme Court of Texas heard argument in Texas Department of State Health Services v. Sky Marketing over whether the agency's scheduling decision that clarified certain forms of THC (including delta-8) is reviewable and what injuries, if any, give businesses standing to sue.

Counsel for the petitioners told the court the challenge focuses on criminal enforcement and that the commissioner lacks criminal-enforcement authority, meaning the trial court lacked jurisdiction to enjoin the commissioner's scheduling decisions. "The commissioner has not threatened enforcement," counsel said, arguing the petition does not assert civil enforcement claims such as license revocation or rule-based penalties.

That framing drew immediate questions from justices about whether respondents actually pleaded civil harms tied to licensing. "What about the civil side? Don't they have authority to revoke license, issue..." a justice asked; petitioners responded those types of allegations were not asserted in the petition.

Respondents' counsel countered that the commissioner's action went beyond a narrow federal-following clarification and instead changed the Texas schedule without required procedural safeguards under the State's administrative scheme. Miss Taylor told the court that required steps under the statute and implementing rulesincluding notice, express findings, and approval by the executive commissionerwere not satisfied for the sort of modification the state enacted. Respondents emphasized record evidence of immediate economic disruption: businesses started to lay off staff and to stop selling products after the announcement appeared on the agency website.

"The website itself is a threat of enforcement," respondents' counsel told the court, arguing that public statements and subsequent local law-enforcement responses caused pocketbook injuries sufficient to establish standing under Texas precedent. Counsel cited earlier cases the justices recognized as relevant to pocketbook-type standing claims.

Justices also questioned the technical and statutory underpinnings of the dispute. Petitioners argued the federal action (and accompanying federal explanation) triggered the commissioner's obligation to act and that Texas's schedules have long defined THC in a way that encompasses delta-8; petitioners' counsel noted federal agency materials (CDC/FDA) describing typical production pathways and argued that manufactured, highly intoxicating concentrations are the agency's concern.

Respondents disputed characterizations that the case turns on —synthetics,— saying the plaintiffs manufacture, sell and use "legal consumable hemp products made from naturally derived substances," and that the administrative change nonetheless altered the legal landscape in a way that harmed license holders.

The justices pressed both sides on practical effects: when the schedule was effectively published and noticed, whether local prosecutors would be able to bring charges, whether the license-regulation regime would be affected, and whether an injunction entered in the trial court would have broader statewide consequences. Counsel disagreed on whether the record rises to the level of a final agency action subject to judicial review or instead reflects an interpretation that is final and unreviewable except by the legislature.

The court took the case under submission after extended questioning. The outcome will determine how Texas defines regulated hemp products and the scope of agency authority to respond to federal scheduling changes and to regulate intoxicating derivatives such as delta-8.

Next steps: the justices have submitted the case for decision; no date was announced for a ruling.